MediPoint: Breast Cancer Imaging - Current and Future Players




$ 3500

In Stock


MediPoint: Breast Cancer Imaging Current and Future Players




Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates and diagnostic imaging is the most widely used technique to achieve early detection, making diagnostic imaging a cornerstone of breast cancer control.


Diagnostic imaging is used for the early detection of breast cancer in asymptomatic patients in population-based screening programs in most developed countries, or for opportunistic screening in developing nations. Regardless of these differences, imaging has proved to be an indispensable tool in fighting breast cancer and has been proven to reduce mortality.




  • Investigation of current and future market competition for breast cancer imaging.
  • Competitor assessment. 
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. 
  • Strategic assessment of the breast cancer imaging segment through market impact analysis, future market scenario and company analysis. 
  • Direct quotes from Key Opinion Leaders (KOLs).


Reasons to buy


  • Gain a high level view of the trends shaping and driving the breast cancer imaging market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. 
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape .
  • Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products. 
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.